Wednesday, October 11, 2023

SOREN BJORN NAMED CEO OF DRISCOLL'S


Soren Bjorn, Driscoll's incoming CEO (Photo: Business Wire)

Soren Bjorn, Driscoll's incoming CEO (Photo: Business Wire)


Current Driscoll’s Chairman and CEO J. Miles Reiter to Retire in January 2024, Become Executive Chairman


WATSONVILLE, Calif., Oct 12 (Bernama-BUSINESS WIRE) -- Driscoll’s Board of Directors has elected Soren Bjorn, currently president of Driscoll’s of the Americas, as the company’s new CEO. He will assume the role in January 2024 and oversee the company’s global day-to-day operations. J. Miles Reiter, the current chairman and CEO of Driscoll’s, has announced his plan to retire at the end of the year and become Executive Chairman of the family-owned company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231010818088/en/
 
 
Bjorn joined Driscoll’s, the world’s berry company, in 2006 and has been involved in nearly every facet of the business over the past 17 years. As the former senior vice president of international business and global technologies, he led business development in Europe, South America, and Australia, as well as global R&D and breeding. He became the leader of Driscoll’s business unit in North America in 2013 and was elevated to his current position as president of Driscoll’s of the Americas in 2017.

Driscoll’s berries are beloved by consumers worldwide, making it one of the top retail grocery brands. As the incoming CEO, Bjorn’s priorities are to maintain the company’s thriving culture and continue accelerating its global growth. Drawing from his experiences leading R&D and innovation, he will also guide the company’s efforts to implement new technologies that improve operational efficiencies and ensure the business remains resilient against industry-wide challenges such as climate change.

“I’m humbled that Miles, the Board, and the thousands of Driscoll’s team members around the world have entrusted me to guide the company into its future,” Bjorn said. “Miles’ legacy is the power and clarity of Driscoll’s mission, vision, and values. He has used them to guide every decision and action for the company. As the new steward of Driscoll’s, I fully commit to all our employees, partners and customers that I will build upon his legacy and honor these same principles.”

An Enduring Legacy

Miles Reiter has been involved in the berry business in some capacity for much of the past 70 years. After college, he became a berry grower in California’s Pajaro Valley in the 1970s and was elected Chairman of the Board of Directors in 1988. Reiter has twice served as the company’s CEO – once from 2000-2015 and again from 2018-present.

“Generations of my family before me and, I suspect, generations after, have been or will be, deeply involved in this always fascinating business,” Reiter said. “A particular pleasure has been to get to know the people who make up our global team of employees, independent growers, industry partners and retail customers, whether it be in the field, at a work site, in the market, over a meal, or best yet, all of the above.”

He added, “It’s now time for me to step aside as CEO. Along with our Board of Directors, I have sought a new leader who is deeply committed to our values, our mission, and a future in which Driscoll’s becomes the world’s berry company, enriching the lives of everyone we touch. It is with great enthusiasm and confidence that we appoint Soren as the new CEO. His deep global knowledge of the berry business, powerful intellect, sound judgment, and contagious sense of humor make him uniquely qualified for this role.”

About Driscoll’s

Driscoll’s is the global market leader of fresh strawberries, blueberries, raspberries, and blackberries. With more than 100 years of farming heritage, Driscoll’s is a pioneer of berry flavor innovation and the trusted consumer brand of Only the Finest Berries™. With more than 900 independent growers around the world, Driscoll’s develops exclusive patented berry varieties using only traditional breeding methods that focus on growing great-tasting berries. A dedicated team of agronomists, breeders, sensory analysts, plant pathologists, and entomologists help grow baby seedlings that are then grown on local family farms. Driscoll’s berries are grown in more than 20 countries and are available for consumers in more than 40 countries across North America, Australia, Europe, and China.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20231010818088/en/

Contact

Frances Dillard
press@driscolls.com

Source : Driscoll’s

KROLL HIRED TO SAFEGUARD CHARGED ASSETS OF GREAT LEARNING, BPL



KUALA LUMPUR, Oct 11 (Bernama) -- Kroll Pte Limited (Kroll) announced that Cosimo Borrelli and Jason Aleksander Kardachi were appointed to safeguard the charged assets of Great Learning Education Pte Ltd (Great Learning) and Byju’s Pte Ltd (BPL).

In a statement, Kroll said the appointment was made on behalf of secured creditors of BYJU’s Alpha Inc, as part of the secured lenders’ exercise of their security rights following defaults by BYJU’s Alpha Inc.

A primary focus of the appointment is to protect and preserve the assets and businesses owned by Great Learning including its subsidiary, Northwest Education Pte Ltd (Northwest Education) and BPL.

The operations of Great Learning and Northwest Education are not impacted by the appointment and all courses and programmes offered by these businesses continue as usual.

Great Learning Founder and Chief Executive Officer, Mohan Lakhamraju continued his leadership of the Great Learning business and management team.

“I am happy to see the Kroll team's commitment towards Great Learning's high quality education and continued growth and look forward to collaborating with them towards the realisation of our mission of enabling career success through transformative learning,” said Lakhamraju.

Kroll is working closely with the management of Great Learning and Northwest Education to ensure the continued delivery of high-quality learning experiences and is committed to the smooth operations and continued growth of their business.

Kroll is the world’s premier provider of services and digital products related to valuation, governance, risk and transparency.

-- BERNAMA

Monday, October 9, 2023

AM BEST RESPONDS FAQ ON NATIONAL SCALE RATINGS



KUALA LUMPUR, Oct 10 (Bernama) -- A new Best’s Commentary has addressed frequently asked questions (FAQ) about Best’s National Scale Ratings (NSR) and how they compare with global Best’s Credit Ratings.

Global credit rating agency, AM Best in a statement said an NSR is a relative measure of the financial strength of insurers and reinsurers that are domiciled in the same country.

The NSR focuses on local insurance market characteristics and allows for a more appropriate comparison among domestic market participants, which over time should allow for greater differentiation among them.

AM Best currently assigns NSRs in Egypt, India, Indonesia, Mexico, the Philippines and Vietnam.

The commentary also addressed other issues such as when an NSR can be assigned; how NSRs are mapped from Best’s Issuer Credit Ratings; and whether country risk can influence an NSR.

Headquartered in the United States, AM Best does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City.

-- BERNAMA

VINCSS NAMED BEST IN CLASS APAC PASSWORDLESS AUTHENTICATION BY FROST & SULLIVAN

 

KUALA LUMPUR, Oct 9 (Bernama) -- VinCSS, ​​a subsidiary of Vingroup has been awarded the 2023 Asia Pacific (APAC) New Product Innovation Award by Frost & Sullivan, following a research of the passwordless authentication landscape.

Based in Ho Chi Minh City, Vietnam, VinCSS stands out as a pioneer in leveraging FIDO2 standards for passwordless authentication, focuses on providing cybersecurity solutions for information technology (IT), Internet of Things (IoT), and Automotive.

“We are continuously evolving, and this accolade is a testament to our dedication. We remain, as always, the industry's trusted partner,” said VinCSS Chief Executive Officer and Founder, Simon Trac Do in a statement.

Meanwhile, Frost & Sullivan global cybersecurity industry principal, Anh Tien Vu said VinCSS sets itself apart from many competitors with a unique and innovative approach enabling customers to deploy its products across different environments while competitors only focus on addressing identity security challenges for the workforce.

Specialising in IT security, identity and access management, IoT security, automotive cybersecurity, VinCSS is consistently breaking new ground and has evolved from a startup to a leader in innovative product development and diversification within the cybersecurity industry.

VinCSS offers comprehensive passwordless authentication solutions via its FIDO2 Ecosystem, strengthening cybersecurity and bringing a significant upgrade in authentication, helping businesses follow authentication rules while making their operations more efficient.

With full control over its product lineup, VinCSS offers competitive pricing in which this strategy solidifies its leading role in the passwordless authentication market.

Beyond being a respected name in cybersecurity, VinCSS is emerging as a prime investment opportunity. As it approaches its financial break-even point and launches its Series B funding round, the company presents significant growth prospects.

-- BERNAMA

Friday, October 6, 2023

UniMed's Credit Ratings Remained Unchanged - AM Best

KUALA LUMPUR, Oct 6 (Bernama) -- New Zealand’s Union Medical Benefits Society Limited (UniMed) financial strength rating of A (Excellent) and “a” (Excellent) long term issuer credit rating which were affirmed on Sept 29, remained unchanged, according to global credit rating agency, AM Best.

This move follows the recently announced Letter of Intent to transfer the insurance portfolio of Accuro Health Insurance Society Limited (Accuro) to UniMed.

In a statement, AM Best said the outlook of these credit ratings (ratings) was stable.

Accuro, like UniMed, is a mutual company writing medical insurance in New Zealand. The proposal to undertake the portfolio transfer remains subject to a vote by Accuro members and regulatory approval by the Reserve Bank of New Zealand.

Subject to receiving these confirmations, the transaction is expected to be completed during the second quarter of 2024 (the fourth quarter of UniMed’s 2024 fiscal year ending 30 June).

Following the portfolio transfer, all Accuro members would become members of UniMed, with their existing cover and benefits remaining in place.

As the transaction progresses, AM Best will monitor the impact on UniMed’s operations and rating fundamentals.

-- BERNAMA


Wednesday, October 4, 2023

GSR Secures In-principle Approval For Singapore Major Payment Institution Licence

KUALA LUMPUR, Oct 3 (Bernama) -- GSR, the global cryptocurrency trading firm and liquidity provider, announced its Singapore subsidiary, GSR Markets Pte Ltd (GSR Singapore) has received In-Principle Approval from the Monetary Authority of Singapore (MAS) for a Major Payment Institution licence.

According to a statement, this licence represents a milestone in the group’s regulatory journey and allows GSR Singapore to better serve the cryptocurrency community.

“We are immensely grateful to MAS for their constructive oversight, which helps shape a growing digital asset ecosystem that we feel proud to be a substantial part of,” said GSR Group Chief Executive Officer, Jakob Palmstierna.

Meanwhile, the group’s Chief Operating Officer, Xin Song said: “We are delighted to be recognised as one of the first firms of our type to be granted this In-Principle Approval from an internationally respected regulator such as MAS.

“MAS has led the way providing a clear framework for digital asset utility, enabling us to deepen our local client partnerships, and continue in our critical role as a liquidity provider within the ecosystem.”

GSR is proud to have met the rigorous admission requirements set by MAS and will be working diligently towards a full licence.

The company remains committed to growing its presence in Singapore, leveraging it as a hub in Asia Pacific to invest in entrepreneurs across the region, and encouraging adoption of Web 3.0 technologies.

-- BERNAMA


Tuesday, October 3, 2023

DYADIC TO PRESENT AT INDUSTRY AND INVESTOR EVENTS IN OCTOBER

JUPITER, Fla., Oct 2 (Bernama-GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be presenting at the following industry and investor events during the month of October:

Enzyme Engineering XXVII, October 1-6, 2023
Park Royal Hotel, Singapore
Dr. Ronen Tchelet, Chief Scientific Officer
“The use of in silico analysis to engineer the best immunogenic epitope and produce the corresponding prophylactic antigen-based vaccines with C1 production platform in order to rapidly respond to viral pandemics”
Wednesday, October 4, 2023, 11:00 AM – 11:30 AM

LD Mirco Main Event XVI, October 3-5, 2023
Luxe Sunset Blvd Hotel, Los Angeles, CA
Mark Emalfarb, President, and Chief Executive Officer
“Next Generation Proteins for World Health, Nutrition and Wellness”
Wednesday, October 4, 2023, 8:00 AM – 8:25 AM

World Vaccine Congress Europe, October 16-19, 2023
Fira de Barcelona Montjuic, Barcelona, Spain
Mark Emalfarb, President, and Chief Executive Officer
“Rapid development and flexible scale manufacturing of complex recombinant proteins and antigens including ferritin nanoparticles for seasonal and pandemic influenza vaccines”
Wednesday, October 18, 2023, 11:45 AM – 12:00 PM

If you would like to connect with Dyadic’s management at any of the events, you may request a one-on-one meeting at jlavalley@dyadic.com.

About Dyadic International, Inc.

Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness.

Dyadic’s gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Our lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is currently used to speed development, lower production costs, and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. Dyadic has also developed the Dapibus™ filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, such as food, nutrition, and wellness. 

With a passion to enable our partners and collaborators to develop effective preventative and therapeutic treatments in both developed and emerging countries, Dyadic is building an active pipeline by advancing its proprietary microbial platform technologies, including our lead asset DYAI-100 COVID-19 vaccine candidate, as well as other biologic vaccines, antibodies, and other biological products.

To learn more about Dyadic and our commitment to helping bring vaccines and other biologic products to market faster, in greater volumes and at lower cost, please visit http://www.dyadic.com.

Safe Harbor Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding Dyadic International’s expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance, such as the success of our clinical trial and interest in our protein production platforms, our research projects and third-party collaborations, as well as the availability of necessary funding. Actual events or results may differ materially from those in the forward-looking statements because of various important factors, including those described in the Company’s most recent filings with the SEC. Dyadic assumes no obligation to update publicly any such forward-looking statements, whether because of new information, future events or otherwise. For a more complete description of the risks that could cause our actual results to differ from our current expectations, please see the section entitled “Risk Factors” in Dyadic’s annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as such factors may be updated from time to time in Dyadic’s periodic filings with the SEC, which are accessible on the SEC’s website and at www.dyadic.com.

Contact:

Dyadic International, Inc.
Ping W. Rawson
Chief Financial Officer
Phone: (561) 743-8333
Email: ir@dyadic.com 

SOURCE: Dyadic International, Inc. 

--BERNAMA